Published in J Clin Pathol on January 01, 1995
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A (2000) 6.85
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med (2000) 3.74
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut (1997) 3.39
Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A (1997) 2.38
Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol (1995) 2.37
Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut (1999) 2.25
Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun (1997) 2.20
Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest (1998) 1.89
Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut (1996) 1.82
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol (1996) 1.81
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun (2007) 1.39
Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun (2001) 1.33
Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol (2001) 1.29
Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem J (2002) 1.27
Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol (2001) 1.22
Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology (2008) 1.21
Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa; an in situ hybridisation study. J Clin Pathol (2004) 1.21
Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun (1998) 1.17
Helicobacter pylori-induced activation of human endothelial cells. Infect Immun (2002) 1.16
Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue. J Clin Pathol (1999) 1.16
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun (1999) 1.11
Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori. Dig Dis Sci (1998) 1.10
implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun (2001) 1.09
Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut (1998) 1.08
cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun (2001) 1.07
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut (1997) 1.07
Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect Immun (2010) 1.05
Retracted Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB. Infect Immun (2001) 1.04
Retracted Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells. Infect Immun (2000) 1.04
Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect Immun (2008) 1.01
Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun (2001) 1.00
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect Immun (2004) 0.98
Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol (1999) 0.98
A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk. PLoS One (2012) 0.96
Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque. Infect Immun (2004) 0.95
Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation. PLoS One (2012) 0.94
CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease. J Clin Microbiol (2000) 0.94
Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island. Infect Immun (2000) 0.94
Differential gene expression from two transcriptional units in the cag pathogenicity island of Helicobacter pylori. Infect Immun (2001) 0.93
Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun (2012) 0.93
The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS One (2012) 0.93
Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infect Immun (1998) 0.93
NF-kappaB activation during acute Helicobacter pylori infection in mice. Infect Immun (2007) 0.92
A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. PLoS One (2009) 0.91
Helicobacter pylori water extract induces interleukin-8 production by gastric epithelial cells. Dig Dis Sci (1999) 0.89
Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon- γ Signaling. Biomed Res Int (2015) 0.89
Expression of Helicobacter pylori virulence factors and associated expression profiles of inflammatory genes in the human gastric mucosa. Infect Immun (2007) 0.88
Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori infection. Clin Exp Immunol (1998) 0.87
H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One (2011) 0.87
Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells. Dig Dis Sci (2006) 0.86
The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunol (2011) 0.84
CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol (2008) 0.84
Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis. J Clin Microbiol (2002) 0.83
Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein. Med Microbiol Immunol (2006) 0.82
Impact of cagPAI and T4SS on the inflammatory response of human neutrophils to Helicobacter pylori infection. PLoS One (2013) 0.82
Serum positive cagA in patients with non-ulcer dyspepsia and peptic ulcer disease from two centers in different regions of Turkey. World J Gastroenterol (2003) 0.82
Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori. Br J Cancer (2005) 0.82
Comparison of CXC chemokines ENA-78 and interleukin-8 expression in Helicobacter pylori-associated gastritis. Infect Immun (2001) 0.82
Interleukin-8 stimulates leukocyte migration across a monolayer of cultured rabbit gastric epithelial cells. Effect associated with the impairment of gastric epithelial barrier function. Dig Dis Sci (1997) 0.81
Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol (2009) 0.81
Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by Helicobacter pylori-infected gastric mucosal epithelium: human glandular stomach as a site of immune privilege. Dig Dis Sci (2000) 0.81
Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells. Infect Immun (2014) 0.80
Positive selection on a bacterial oncoprotein associated with gastric cancer. Gut Pathog (2011) 0.80
Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol (2001) 0.80
Relationship between Helicobacter pylori virulence factors and regulatory cytokines as predictors of clinical outcome. Microbes Infect (2007) 0.80
Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. Dig Dis Sci (2003) 0.80
NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci (2002) 0.79
Co-expression in Helicobacter pylori of cagA and non-opsonic neutrophil activation enhances the association with peptic ulcer disease. J Clin Pathol (2000) 0.79
IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis. Mediators Inflamm (2016) 0.79
Dynamic Expansion and Contraction of cagA Copy Number in Helicobacter pylori Impact Development of Gastric Disease. MBio (2017) 0.78
Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori. Inflammopharmacology (1998) 0.78
Antigenic diversity and serotypes of Helicobacter pylori associated with peptic ulcer diseases. Korean J Intern Med (1998) 0.78
The inflammatory response in CD1 mice shortly after infection with a CagA+/VacA+ Helicobacter pylori strain. Clin Exp Immunol (1999) 0.77
Pathogenic diversity of Helicobacter pylori. J Gastroenterol (1997) 0.77
The role of C1q in recognition of apoptotic epithelial cells and inflammatory cytokine production by phagocytes during Helicobacter pylori infection. J Inflamm (Lond) (2015) 0.76
Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. BMC Cancer (2017) 0.75
Helicobacter pylori associated Asian enigma: Does diet deserve distinction? World J Gastrointest Oncol (2016) 0.75
Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis. Front Microbiol (2016) 0.75
The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori. Cent Eur J Immunol (2016) 0.75
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Dig Dis Sci (2003) 0.75
Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis. Saudi J Gastroenterol (2017) 0.75
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol (1994) 11.21
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med (1994) 6.24
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun (1993) 5.63
Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol (1989) 4.86
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
H pylori-initiated ulcerogenesis: look to the host. Lancet (1993) 3.94
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci U S A (1988) 3.37
Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun (1993) 2.83
Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest (1993) 2.65
Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol (1992) 2.60
Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut (1993) 1.99
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut (1992) 1.94
Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut (1992) 1.81
Genetics of Campylobacter and Helicobacter. Annu Rev Microbiol (1992) 1.65
Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology (1992) 1.49
Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis (1992) 1.44
Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library. Infect Immun (1985) 1.28
Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains. J Clin Pathol (1994) 0.88
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
Helicobacter pylori virulence and genetic geography. Science (1999) 7.64
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science (1998) 6.99
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med (1994) 6.24
Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A (2006) 4.40
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
DNA element of Corynebacterium diphtheriae with properties of an insertion sequence and usefulness for epidemiological studies. J Bacteriol (1987) 3.26
Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol (2001) 2.99
Mutants of pertussis toxin suitable for vaccine development. Science (1989) 2.89
Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood (1969) 2.71
The NIH consensus-development program and the assessment of health-care technologies: the first two years. N Engl J Med (1980) 2.69
Risk of neoplasia in renal transplant patients. Lancet (1995) 2.65
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci U S A (1995) 2.63
Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol (1992) 2.60
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Families of bacterial signal-transducing proteins. Mol Microbiol (1989) 2.59
Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun (1987) 2.59
Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut (2000) 2.56
Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect Immun (1998) 2.54
The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res (1983) 2.51
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44
Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A (1997) 2.38
Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol (1995) 2.37
Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol (1997) 2.33
Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci U S A (1995) 2.33
Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis. Proc Natl Acad Sci U S A (1990) 2.27
Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg (1998) 2.24
Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol (1993) 2.24
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci U S A (1994) 2.19
Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol (1993) 2.17
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun (1996) 2.14
Positive regulation of pertussis toxin expression. Proc Natl Acad Sci U S A (1988) 2.13
The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA (2000) 2.12
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J (1997) 2.11
Structural and genetic analysis of the bvg locus in Bordetella species. Mol Microbiol (1991) 2.09
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci U S A (2008) 2.02
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1993) 2.02
RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol (2007) 2.01
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Promoter of the pertussis toxin operon and production of pertussis toxin. J Bacteriol (1987) 1.98
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med (1998) 1.98
Survival of Helicobacter pylori in water and saline. J Clin Pathol (1990) 1.97
Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem (2000) 1.97
The Fur repressor controls transcription of iron-activated and -repressed genes in Helicobacter pylori. Mol Microbiol (2001) 1.96
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A (1998) 1.95
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
The prevalence and nature of recent self-reported changes in general dental practice in a sample of English general dental practitioners. Br Dent J (2004) 1.93
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest (1998) 1.89
Pertussis toxin export requires accessory genes located downstream from the pertussis toxin operon. Mol Microbiol (1993) 1.89
Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J (1999) 1.88
Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor. Mol Microbiol (1990) 1.88
Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol (1991) 1.84
Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol (1996) 1.82
Introduction of unmarked mutations in the Helicobacter pylori vacA gene with a sucrose sensitivity marker. Infect Immun (1997) 1.82
The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect (2001) 1.81
Comparison of Phadebact coagglutination tests with counterimmunoelectrophoresis for the detection of bacterial antigens in cerebrospinal fluid. J Clin Pathol (1983) 1.81
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun (1995) 1.79
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine (1992) 1.78
Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microbiol (1994) 1.75
Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol (1994) 1.74
Sequential activation and environmental regulation of virulence genes in Bordetella pertussis. EMBO J (1991) 1.73